Omada Health Inc. (OMDA)
OMDA trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1611115/000162828026015637/0001628280-26-015637-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | OMDA on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0001611115 |
| SEC industry code | Services-Health Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $260.2M |
| Net income | -$12.8M |
| Operating income | -$12.0M |
| Net margin | -4.9% |
| Operating margin | -4.6% |
| Revenue growth | +53.2% |
| Cash | $222.0M |
| Total assets | $305.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.5× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-06 |
| Cash and burn | $243.2M cash; operating cash flow $7.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 62,037,725 (2026-11-03); 57,908,047 a year earlier. | Cover page 2026-11-03 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, San Francisco, California, United States | PCAOB Form AP 2026-03-19 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $11.9M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $91.3M | $6.6M | $15.1M | $243.2M | No debt tags | $333.0M | 10-Q 2026-11-06 |
| Q2 2026 2026-06-30 | $87.8M | $5.3M | $4.0M | $221.7M | No debt tags | $309.8M | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | $78.0M | -$3.0M | -$11.8M | $211.8M | No debt tags | $283.3M | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $75.8M | $5.2M | $21.4M | $222.0M | $0 | $260.2M | 10-K 2026-03-06 |
| Q3 2025 2025-09-30 | $68.0M | -$3.2M | $10.1M | $198.6M | $0 | $232.3M | 10-Q 2026-11-06 |
| Q2 2025 2025-06-30 | $61.4M | -$5.3M | $2.9M | $223.1M | $30.0M | $209.8M | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | $55.0M | -$9.4M | -$16.1M | $59.4M | No debt tags | $189.7M | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $48.0M | -$8.3M | -$6.5M | $76.4M | $29.8M | $169.8M | 10-K 2026-03-06 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-06-09 |
| Latest annual report | 10-K | 2026-03-06 |
| Latest quarterly / interim | 10-Q | 2026-11-06 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 240 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.0% |
| 1 month | -21.7% |
| 3 months | -41.2% |
| Year to date | -9.2% |
| 1 year | -31.0% |
| From 52-week high | -42.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| SBC | SBC Medical Group Holdings Incorporated | $6.18 | -15.92% | $635.6M |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| SRTA | Strata Critical Medical Inc. | $5.42 | -1.63% | $484.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier